Organisers

 

Karim Meeran (UK)

Karim Meeran (UK)

Professor Meeran qualified from the Royal Free Hospital in 1988 and trained in Endocrinology at Hammersmith Hospital and St Bartholomew’s Hospital. He is Professor of Endocrinology, Deputy Director of Medical Education and Lead Clinician for Endocrinology. He has established a strong clinical and educational link with the Abu Dhabi Imperial College London Diabetes Centre. He has an international reputation for the treatment of endocrine disease and has published extensively in this field. Professor Meeran’s clinical focus is in all aspects of endocrinology and diabetes including thyroid, adrenal, prolactin and pituitary diseases, parathyroid, calcium, vitamin D and bone metabolism and neuroendocrine tumours.

Mark Gurnell (UK)

Mark Gurnell (UK)

Mark Gurnell is Professor of Clinical Endocrinology in Cambridge, where he leads endocrine specialist services. He is also SubDean in the University of Cambridge School of Clinical Medicine, and Head of Undergraduate Assessment. His clinical and research interests are focussed on pituitary, adrenal and thyroid disorders, with particular interests in acromegaly, TSH-secreting pituitary adenomas and primary aldosteronism. As head of the Cambridge Endocrine Molecular Imaging Group (CEMIG), he has led the development of novel techniques for functional imaging and has overseen the introduction of national specialist PET services for pituitary and adrenal disorders. He is also recognised as an expert in the management of patients with unusual thyroid function tests. He currently serves on the Council of the UK Society for Endocrinology (as Treasurer-elect), the Education Committee of the European Society of Endocrinology, the Endocrine Society’s ESAP panel, and the Royal College of Physicians (UK) Specialty Certificate Examinations Board (Endocrinology & Diabetes). He holds a number of senior appointments in medical education and chairs the the Board of the UK Medical Schools Council Assessment Alliance.

Mirjam Christ-Crain: Chair of the Education Committee, 2020-2024

Mirjam Christ-Crain: Chair of the Education Committee, 2020-2024

Mirjam Christ-Crain is full Professor of Endocrinology, Diabetes and Metabolism at the University of Basel and the University Hospital of Basel, Switzerland. She studied medicine in Basel and Vienna and did her MD in the year 2000 at the University of Basel and her PhD 2007 at the University of London followed by her habilitation at the University of Basel in 2007. From 2009 to 2015 she had a research professorship of the Swiss National Science Foundation. Her main research interest is on vasopressin-dependent disorders of fluid homeostasis, i.e. diabetes insipidus and hyponatremia. She authored and co-authored more than 200 publications including high-ranked publications in the New England Journal of Medicine and The Lancet and received several honours and awards for her research, most recently the European Journal of Endocrinology Award 2019. Since 2013 she is Deputy Chief at the Clinic for Endocrinology, University Hospital Basel and since 2014 she is Head of the Department of Clinical Research at the University of Basel.

Heide Siggelkow (Germany)

Heide Siggelkow (Germany)

Prof. Dr. Heide Siggelkow is associate professor for Endocrinology at the Clinic of Gastroenterology, Gastrointestinal Oncology and Endocrinology, Head of the Working Group of Molecular Endocrinology and Osteology at the University Medical Center, Göttingen and Medical Director of the MVZ Endokrinologikum. She works in an outpatient clinic for endocrine or metabolic bone diseases including osteoporosis, hypoparathyroidism, hyperparathyroidism and rare bone diseases. Between 2011 and 2015, she was head of the Association of German Language Societies in the special Field of Osteology (DVO). In this position, she initiated and supported the development of the Osteologic Research Centers DVO. She has been president of the German Society of Osteology (DGO) from 2017–2019. In 2017, the Intensive Course for Clinical Endocrinology of the German Society of Endocrinology (DGE) took place in Göttingen under her leadership, and in 2019 she hosted the yearly congress of the society DGE in Göttingen. Since 2018, she has been spokesperson of the German network of rare bone diseases, “Netzwerk für seltene Osteopathien NetsOs”. 2017-2020 she was member of the European Calcified Tissue Society (ECTS) Website and Social Media Action Group, since 2021 she joined the ECTS Action group of Rare Bone Diseases. Since 2020 she is member of the ESE Education committee and representative in the PARAT programme of the European Society of Endocrinology (ECE). Her basic scientific work focuses on molecular and metabolic mechanisms important for the interplay between fat and bone in primary and secondary forms of osteoporosis, with a special focus on cortisol and bone. Another main topic was the investigation of mechanisms of osteoporosis in chronic inflammatory bowel diseases. Her clinical research is now concentrated on secondary forms of osteoporosis and on hypoparathyroidism with a special focus on quality of life.

Daniele Santi (Italy)

Daniele Santi (Italy)

Dr. Daniele Santi graduated with Honors from the Medical School of the University of Modena and Reggio Emilia, Italy in 2008. He obtained with Honors the specialization in Endocrinology and Metabolism in 2014 and his PhD in Clinical and Experimental Medicine in 2017 from the University of Modena and Reggio Emilia. Currently, Dr. Santi works as Assistant Professor at the Unit of Endocrinology of the Department of Biomedical, Metabolic and Neural Sciences of the University of Modena and Reggio Emilia, Italy. He has published a large number of scientific manuscripts in peer-reviewed journals, in the field of Endocrinology, Andrology and Reproductive medicine. He obtained the ESE young investigator awards in 2015. Dr. Santi is a member of the editorial boards or reviewer in high impact scientific journals and an active member of scientific committees and societies. The main fields of the research are reproduction and the gonadotropins physiology and implications in clinical practice. Currently, his researches are involved in the environmental and epigenetics influences on the hypothalamic-pituitary-gonadal axis in the male and in the role of gonadotropins on human reproduction.

Gerald Raverot (France)

Gerald Raverot (France)

Dr. Raverot is Professor in Endocrinology at Lyon 1 University and is chief of the Reference Center of Rare Pituitary Disease and the Endocrine Department at Hospices Civils of Lyon. He leads a research team dedicated to “Pathophysiology of pituitary tumors” at the INSERM Research Center. He coordinated the European Society of Endocrinology guidelines on aggressive pituitary tumors and carcinoma. His major research interests are pituitary tumor pathogenesis and identification of prognosis markers allowing the development of potential new therapies. He served on boards of the French Society of Endocrinology, the Endocrine Society, and the European Society of Endocrinology, and has been elected to the European Neuroendocrine Association executive committee.

Mark Sherlock (Ireland)

Mark Sherlock (Ireland)

Maeve Durkan (Ireland)

Maeve Durkan (Ireland)

Dr Durkan is an RCSI graduate ,with post graduate and sub specialty Diabetes & Endocrinology training in the UK . Thereafter she completed second residency in Internal Medicine at Yale University School of Medicine, USA and subsequently a fellowship in Diabetes, Endocrinology & Metabolism at Brown University School of Medicine, USA. She is a Diplomat of the American Board of Internal Medicine, a Diplomat of the American Board of Diabetes, Endocrinology & Metabolism and a Fellow of the American College of Physicians. She was awarded a Masters in Clinical Education NUI Galway in 2012. She is a consultant Endocrinologist , in the BSH Cork and a Senior Clinical Lecturer in Medicine in UCC School of Medicine,' . She also lectures for the UCC School of Pharmacy , She is involved clinical research , presenting annually at both the American Diabetes & American Endocrine International scientific meetings. She has just had two papers accepted for oral presentation at the IFSO ( International Federation for the Surgery of Obesity & Metabolic Disorders) annual scientific meeting in Miami, USA this year . She is an Internal Examiner for the MD Thesis Program at NUI Galway, and a peer reviewer for the Irish Journal of Medical Science.' She is President of UEMS (European Union Committee for Medical Specialties), Board of Endocrinology. She was appointed to the UEMS Examination committee to progress the European Board Exam in Endocrinology in partnership with the ESE (European Society for Endocrinology) with the first specialty exam ( EBEEDM) delivered in June 2018. She is co-author of the UEMS ETR (European Training Requirement) in Diabetes & Endocrinology that was ratified at the UEMS Council meeting in 2017. She is the current Vice Chair of UEMS CESMA (Council for European Specialists Medical assessments), having been appointed to the CESMA European examination appraisals subcommittee in 2016. She is the former Chair of the Diabetes division of the Irish Endocrine Society She was Co – Chair of the National Committee R3i (Residual Risk Reduction) Ireland and is now part of a working national lipid network group currently establish a National Lipid Screening Program.